Anti-proliferative effects of lichen-derived lipoxygenase inhibitors on twelve human cancer cell lines of different tissue origin in vitro

Planta Medica

Volumn 70, Issue 11, 2004, Pages 1098-1100

  Haraldsdóttir, Sigurdís ^a,b   Guolaugsdóttir, Erna ^a,b   Ingólfsdóttir, Kristín ^b   Ögmundsdóttir, Helga M ^a,b,c  

^a ICELANDIC CANCER SOCIETY   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c Faculty of Medicine   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; BAEOMYCESIC ACID; LIPOXYGENASE; LIPOXYGENASE INHIBITOR; LOBARIC ACID; PROTOLICHESTERINIC ACID; UNCLASSIFIED DRUG; ZILEUTON;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROLIFERATION; CONCENTRATION RESPONSE; DRUG EFFECT; DRUG SELECTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LICHENS; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; HUMANS; LICHENS; LIPOXYGENASE INHIBITORS; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 9744257738     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-832657     Document Type: Article

References (12)

1. Ingólfsdóttir K, Breu W, Huneck S, Gudjónsdó ttir GA, Müller-Jakic B, Wagner H. In vitro inhibition of 5-lipoxygenase by protolichesterinic acid from Cetraria islandica. Phytomedicine 1994; 1: 187-91
2. Ingólfsdóttir K, Gissurarson SR, Müller-Jakic B, Breu W, Wagner H. Inhibitory effects of the lichen metabolite lobaric acid on arachidonate metabolism in vitro. Phytomedicine 1996; 2: 243-6
3. Ingólfsdóttir K, Birgisdóttir M, Wiedermann B, Nenninger A, Jónsdóttir S, Wagner H. Inhibitory effects of baeomycesic acid from Thamnolia subuliformis on arachidonate metabolism. Phytomedicine 1997; 4: 125-8
4. Bucar F, Schneider I, Ögmundsdóttir H, Ingó lfsdóttir K. Anti-proliferative lichen compounds with inhibitory activity on 12(S)-HETE production in human platelets. Phytomedicine, 2004: in press
5. Ghosh J, Myers CE. Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem Biophys Res Commun 1997; 235: 418-23
6. Ding XZ, Iversen P, Cluck MW, Knezetic JA, Adrian TE. Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells. Biochem Biophys Res Commun. 1999; 261: 218-23
7. Rioux N, Castonguay A. Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents. Carcinogenesis 1998; 19: 1393-400
8. Tong WG, Ding XZ, Adrian TE. The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells. Biochem Biophys Acta 2002; 296: 942-8
9. Ögmundsdóttir HM, Zoëga GM, Gissurarson SR, Ingólfsdóttir K. Antiproliferative effects of lichen-derived inhibitors of 5-lipoxygenase on malignant cell lines and mitogen-stimulated lymphocytes. J Pharm Pharmacol 1998;50:107-15
10. Carter GW, Young PR, Albert DH, Bouska J, Dyer R, Bell RL et al. 5-Lipoxygenase inhibitory activity of zileuton. J Pharmacol Exp Ther 1991;256:929-37
11. Hussey HJ, Tisdale MJ. Inhibition of tumour growth by lipoxygenase inhibitors. Br J Cancer 1996; 74: 683-7
12. Cordell GA, Kinghorn D, Pezzuto JM. Separation, structure elucidation and bioassay of cytotoxic natural products. In: Molyneux RJ, editor. Bioactive natural products Boca Raton: CRC Press, 1993: pp 195-216